Michael Chang

No open positions remaining

75 year

Health Technology

Consumer Services

Consumer Non-Durables

Profile

Michael N.
Chang is the founder of Optimer Pharmaceuticals LLC (1998), Pharmanex, Inc. (1994), and OBI Pharma, Inc. (2002).
At Optimer Pharmaceuticals LLC, he held the title of Director from 1998 to 2013.
At Pharmanex, Inc., he held the title of Chief Science Officer, SVP-Research & Development.
At OBI Pharma, Inc., he held the title of Chairman & Spokesman.
Dr. Chang's former jobs include Director-Drug Development Division at Rhone-Poulenc Rorer, Inc., Deputy Director-Pharmaceutical Chemistry at Merck Sharp & Dohme (I.A.) Corp.
(Taiwan), Director at Ansun Biopharma, Inc., Vice President-Pharmaceutical Department at ArQule, Inc., and Chief Scientific Officer at Nu Skin Enterprises, Inc. from 1998 to 2000.
He was also a Partner at Delos Advisors Ltd. Dr. Chang received a doctorate degree from Brandeis University and an undergraduate degree from Fu Jen Catholic University.

Former positions of Michael Chang

Companies	Position	End
Optimer Pharmaceuticals LLC Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes anti-infective products	Chief Executive Officer	05/05/2010
NU SKIN ENTERPRISES, INC.	Chief Tech/Sci/R&D Officer	01/01/2000
Ansun Biopharma, Inc. Ansun Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Director/Board Member	-
Delos Advisors Ltd. Delos Advisors Ltd. Investment ManagersFinance Delos Capital invests in companies located in Greater China and in the United States. The firm targets companies operating in the fields of life sciences, therapeutics and medtech devices sectors. It provides financing for buyout, direct or indirect private equity investments, restructuring, recapitalizations, strategic investments and growth stage capital requirements. It also makes investments in public listed companies.	Private Equity Investor	-
Merck Sharp & Dohme (I.A.) Corp. (Taiwan)	Corporate Officer/Principal	-

See the detail of Michael Chang's experience

Training of Michael Chang

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Michael Chang's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	11
ArQule, Inc. ArQule, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches and develops therapeutics to treat cancers & rare diseases	Health Technology
Nu Skin Enterprises, Inc. Nu Skin Enterprises, Inc. Household/Personal CareConsumer Non-Durables Develops and distributes personal care products and nutritional supplements	Consumer Non-Durables
Rhone-Poulenc Rorer, Inc. Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets human pharmaceuticals	Health Technology
Brandeis University Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Optimer Pharmaceuticals LLC Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes anti-infective products	Health Technology
Pharmanex, Inc. Pharmanex, Inc. Food RetailRetail Trade Provides dietary supplements products	Retail Trade
Merck Sharp & Dohme (I.A.) Corp. (Taiwan)
Fu Jen Catholic University Fu Jen Catholic University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
OBI Pharma, Inc. OBI Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures anti-infective and immunotherapy drugs	Health Technology
Ansun Biopharma, Inc. Ansun Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
Delos Advisors Ltd. Delos Advisors Ltd. Investment ManagersFinance Delos Capital invests in companies located in Greater China and in the United States. The firm targets companies operating in the fields of life sciences, therapeutics and medtech devices sectors. It provides financing for buyout, direct or indirect private equity investments, restructuring, recapitalizations, strategic investments and growth stage capital requirements. It also makes investments in public listed companies.	Finance